In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>

• Main Authors: Jacinda C. Abdul-Mutakabbir (Author), Juwon Yim (Author), Logan Nguyen (Author), Philip T. Maassen (Author), Kyle Stamper (Author), Zain Shiekh (Author), Razieh Kebriaei (Author), Ryan K. Shields (Author), Mariana Castanheira (Author), Keith S. Kaye (Author), Michael J. Rybak (Author)
• Format: Book
• Published: MDPI AG, 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<i>Acinetobacter baumannii</i> is currently classified as one of six pathogens that contribute to increased patient mortality. Thus, exploratory studies navigating alternative treatment strategies are of supreme interest. Herein, we completed minimum inhibitory concentration (MIC) testin...